Photo from wikipedia
PCSK9 inhibitor (PCSK9i) use continues to rise; however, access is limited. Herein, we describe our experience at a cardiology-based community lipid clinic with a focus on payer origin and intolerance… Click to show full abstract
PCSK9 inhibitor (PCSK9i) use continues to rise; however, access is limited. Herein, we describe our experience at a cardiology-based community lipid clinic with a focus on payer origin and intolerance rates. Queries for the clinic population on PCSK9i use were performed using the “Slicer-Dicer
Keywords:
community;
lipid clinic;
pcsk9 inhibitor;
cardiology;
use
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!